Market cap
$7.2bn
Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
Results of Operations The following is a summary of our financial results (in millions): Revenue Total revenue for the three and six months ended June 30, 2026 was $267.9 million and $514.0 million, respectively, compared to $452.0 million and $583.7 million for the same periods in 2025, respectively, and was comprised of the following (in millions): Commercial revenue for the three months and six months ended June 30, 2026 increased 15% and 27%, respectively, compared to the same periods in 2025. This increase was primarily driven by DAWNZERA product sales. …IONIS PHARMACEUTICALS INC, 10-Q, period ended 2026-06-30, filed 2026-07-29